Elite Trades From Anywhere Elite Trades All Summer

$100 Off + One Summer Month Free Get Elite For Just $199.50

Peers: UNH CI HUM CNC MOH CVS HCA UHS MCK COR

| Held by: VTI VOO IVV SPY VTV XLV VIG VYM VHT IWD

Index	S&P 500	P/E	16.81	EPS (ttm)	23.50	Insider Own	0.30%	Shs Outstand	217.37M	Perf Week	1.72%
Market Cap	85.82B	Forward P/E	13.52	EPS next Y	29.24	Insider Trans	-0.35%	Shs Float	216.51M	Perf Month	0.95%
Enterprise Value	-	PEG	3.37	EPS next Q	6.20	Inst Own	93.81%	Short Float	2.90%	Perf Quarter	34.30%
Income	5.24B	P/S	0.43	EPS this Y	-11.17%	Inst Trans	-2.20%	Short Ratio	3.61	Perf Half Y	15.14%
Sales	200.41B	P/B	1.96	EPS next Y	8.66%	ROA	4.27%	Short Interest	6.28M	Perf YTD	12.73%
Book/sh	201.97	P/C	-	EPS next 5Y	4.01%	ROE	12.14%	52W High	426.98 -7.45%	Perf Year	5.90%
Cash/sh	-	P/FCF	13.31	EPS past 3/5Y	1.27% 6.99%	ROIC	7.02%	52W Low	273.71 44.38%	Perf 3Y	-11.94%
Dividend Est.	6.98 (1.77%)	EV/EBITDA	-	Sales past 3/5Y	8.34% 10.32%	Gross Margin	-	Volatility	2.48% 2.64%	Perf 5Y	3.77%
Dividend TTM	6.86 (1.74%)	EV/Sales	-	EPS Y/Y TTM	-8.53%	Oper. Margin	3.81%	ATR (14)	10.48	Perf 10Y	212.69%
Dividend Ex-Date	Jun 10, 2026	Quick Ratio	-	Sales Y/Y TTM	9.44%	Profit Margin	2.62%	RSI (14)	51.92	Recom	1.80
Dividend Gr. 3/5Y	10.14% 12.47%	Current Ratio	1.48	EPS Q/Q	-16.70%	SMA20	-1.05%	Beta	0.67	Target Price	413.76
Payout	27.13%	Debt/Eq	0.73	Sales Q/Q	2.64%	SMA50	3.36%	Rel Volume	1.66	Prev Close	387.32
Employees	97100	LT Debt/Eq	0.70	Earnings	Apr 22 BMO	SMA200	15.16%	Avg Volume	1.74M	Price	395.18
IPO	Oct 30, 2001	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.28% 2.68%	Trades		Volume	2,913,683	Change	2.03%

Date	Action	Analyst	Rating Change	Price Target Change
May-20-26	Upgrade	Deutsche Bank	Hold → Buy	$498
Apr-29-26	Upgrade	BofA Securities	Neutral → Buy	$435
Apr-08-26	Initiated	Evercore ISI	In-line	$345
Feb-03-26	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$358
Jan-08-26	Upgrade	Wolfe Research	Peer Perform → Outperform	$425
Dec-19-25	Downgrade	Deutsche Bank	Buy → Hold	$320
Oct-14-25	Initiated	Goldman	Neutral
Jul-21-25	Downgrade	Argus	Buy → Hold
Jul-18-25	Downgrade	Leerink Partners	Outperform → Market Perform	$310
Apr-15-25	Downgrade	Robert W. Baird	Outperform → Neutral	$529
Mar-17-25	Upgrade	Argus	Hold → Buy	$450
Jan-22-25	Downgrade	Stephens	Overweight → Equal-Weight	$520 → $440
Oct-18-24	Downgrade	Argus	Buy → Hold
Jul-18-24	Downgrade	BofA Securities	Buy → Neutral	$646 → $530
Jun-24-24	Initiated	Morgan Stanley	Overweight	$643
May-30-24	Initiated	Robert W. Baird	Outperform	$649
Mar-06-24	Initiated	Barclays	Overweight	$584
Jul-12-23	Downgrade	Wolfe Research	Outperform → Peer Perform
Apr-27-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$500 → $571
Apr-21-23	Initiated	Cantor Fitzgerald	Overweight	$547

Show Previous Ratings

Jun-17-26 10:00AM	Elevance Health Announces $640 Million Investment in Affordable Housing Over the Past Five Years, Surpassing $1 Billion in Total Commitment Nationwide (Business Wire)
05:30AM	The Medicare Crisis for Insurers Is Over. The Easy Gains Are Too. (The Wall Street Journal)
Jun-16-26 11:44AM	Why Did UnitedHealth Stock Choose Pain Over Growth? (Trefis)
Jun-05-26 04:20PM	Can UNH Stock Sustain Its Recent 40% Rally? (Trefis)
Jun-04-26 12:38PM	UnitedHealth Stock Rises. Why the Health Insurer Is Leading the Dow to Sharp Gains. (Barrons.com)
04:54AM	Loading…
Jun-01-26 04:54AM	Elevance again avoids Medicare Advantage sanctions, but threat remains (Healthcare Dive)
May-20-26 09:43AM	Cigna downgraded, Humana upgraded: Wall Street's top analyst calls (The Fly)
09:35AM	Deutsche Bank sees new upswing for health insurers after years of margin pressure (Investing.com)
May-07-26 08:47PM	Myomo, Inc. Q1 2026 Earnings Call Summary (Moby)
May-04-26 02:10PM	Elevance Health Advances Efforts to Close Critical Gaps in Mental Health Care (Business Wire)
Apr-30-26 08:00AM	Elevance Healths Affiliated Health Plans Deliver More Predictable, Lower Healthcare Costs for Small Businesses (Business Wire)
Apr-29-26 02:06PM	Elevance Health and 2 More Stocks to Buy. Better Days Are Ahead for Medicaid Providers. (Barrons.com)
09:42AM	Spotify upgraded, Alibaba initiated: Wall Street's top analyst calls (The Fly)
07:34AM	Analysts upgrade Elevance, Centene shares as Medicaid margins expected to recover (Investing.com)
Apr-23-26 08:03AM	Molina controls costs in Q1 but future Medicaid spending in doubt (Healthcare Dive) +5.51%
03:02AM	Loading…
03:02AM	Elevance Health Inc (ELV) Q1 2026 Earnings Call Highlights: Strong EPS Growth and Raised Guidance (GuruFocus.com)
Apr-22-26 12:45PM	Elevance Health Inc. Q1 2026 Earnings Call Summary (Moby)
07:55AM	Elevance perks up in 2026 though Medicare Advantage payout could ding profits (Healthcare Dive)
06:07AM	Elevance Health: Q1 Earnings Snapshot (Associated Press)
06:00AM	Elevance Health Reports First Quarter 2026 Results; Raises Full-Year Guidance (Business Wire)
Apr-21-26 09:17AM	UnitedHealth Says Turnaround Has a Long Way to Go. Earnings, Stock Say Otherwise. (Barrons.com)
Apr-14-26 04:59AM	California judge tosses Elevances surprise billing suit in win for providers (Healthcare Dive)
Apr-11-26 08:16AM	Elevance Health: The Multi-Year Re-Rating Opportunity (GuruFocus.com)
Apr-08-26 09:42AM	Coinbase downgraded, Deere upgraded: Wall Street's top analyst calls (The Fly)
Apr-07-26 06:03PM	Health Insurers Rally After CMS Rate Surprise (GuruFocus.com)
11:04AM	Health-Insurance Stocks Rally on Increased Payments for Medicare Advantage Insurers (The Wall Street Journal)
09:48AM	Stocks to Watch: UnitedHealth, Humana, Universal Music Group, Broadcom (The Wall Street Journal)
04:36AM	Health insurers secured a better Medicare Advantage rate for 2027, and their stocks are soaring (MarketWatch)
Apr-06-26 05:51PM	UnitedHealth, Humana, Health Insurers Jump On Higher Medicare Advantage Payments (Investor's Business Daily)
04:58PM	Humana shares surge 12% on 2027 Medicare rate boost; UNH, CVS rally (Investing.com)
11:54AM	Loading…
Apr-02-26 11:54AM	It's not just patients who are sick of fighting health insurers. Doctors are frustrated, too. (MarketWatch)
Apr-01-26 06:33AM	Elevance sidesteps Medicare Advantage sanctions for now (Healthcare Dive)
Mar-31-26 09:00AM	Elevance Health Announces Leadership Appointments to Strengthen Execution and Drive Growth (Business Wire)
04:58AM	Elevance fills slew of mid-level leadership positions (Healthcare Dive)
Mar-30-26 04:30PM	Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2026 Results on April 22, 2026 (Business Wire)
Mar-29-26 10:29AM	Trump calls for replacing Obamacare with direct payments to Americans (Investing.com)
Mar-10-26 01:41PM	Centene Is the Worst S&P 500 Stock Today. What's Ailing the Health Insurer. (Barrons.com)
Mar-09-26 11:56AM	UNH Deploys AI in Optum Rx to Tackle Pharmacy Fraud and Cost Leakage (Zacks)
Mar-03-26 10:00AM	Elevance Health and National Diaper Bank Network Launch National Pilot to Address Diaper Affordability and Improve Family Health (Business Wire)
04:25AM	CMS threatens Elevance with Medicare Advantage sanctions (Healthcare Dive)
Mar-02-26 05:05PM	These Stocks Are Todays Movers: AES, Norwegian, Elevance, Palantir, Lockheed, Strategy, Berkshire Hathaway, and More (Barrons.com) -8.10%
04:38PM	Stocks to Watch Monday Recap: Norwegian Cruise Line, United Airlines, Lumentum, Elevance (The Wall Street Journal)
04:37PM	Stocks Recover as Iran War Pushes Energy and Defense Stocks Higher (Barchart)
04:01PM	NvidiaCoherent deal, Paramount+ to be combined with HBO Max (Yahoo Finance Video)
01:19PM	Palantir, Energy Stocks Rally, Cruise Lines Tumble On US And Israeli-Iran War: What's Moving Markets Monday? (Benzinga)
12:30PM	Elevance Health Stock Sinks After CMS Freezes Medicare Advantage Enrollment (Benzinga)
12:12PM	Stocks to Watch Monday: Norwegian Cruise Line, United Airlines, Lumentum, Elevance (The Wall Street Journal)
11:19AM	Markets Rebound After Initial Selloff Triggered by Middle East Tensions (Barchart)
10:53AM	Analyst Report: Elevance Health, Inc. (Morningstar Research)
09:25AM	Elevance Health Stock Slips. CMS to Halt Enrollment in Prescription Drug Plans. (Barrons.com)
07:35AM	Is Elevance Health Stock Underperforming the Dow? (Barchart)
Feb-27-26 05:45AM	Elevance shuffles C-suite as top Carelon exec departs (Healthcare Dive)
Feb-26-26 03:02PM	Elevance Health Announces Management Changes; CFO Mark Kaye to Expand Responsibilities to Include Carelon and Felicia Norwood to Lead Consolidated Health Benefits Organization (Business Wire)
Feb-25-26 12:42PM	After stints at Nike and Kohls, Elevance Healths CDIO pivots to using tech to bring more delight to health care (Fortune)
12:14PM	Acadia Healthcare Q4 Earnings Beat Estimates on Rising Admissions (Zacks)
Feb-24-26 10:06AM	Is UnitedHealth Stock Underperforming the Dow? (Barchart)
08:45AM	UnitedHealthcare Under Pressure: Can UNH's Core Business Rebound? (Zacks)
Feb-20-26 11:55AM	Select Medical Q4 Earnings Miss Estimates on Increasing Expenses (Zacks)
Feb-19-26 04:02PM	World's Largest Hedge Fund Buys Dell and UnitedHealth, Sells AT&T Stock (Barrons.com)
Feb-18-26 04:50PM	Warren Buffett Disciple Seth Klarman Differs With Mentor On This Magnificent Seven Stock: One Is Buying, One Is Selling (Benzinga)
07:09AM	Is Wall Street Bullish or Bearish on Elevance Stock? (Barchart)
Feb-17-26 06:01PM	Glenn Greenberg's Strategic Moves: Elevance Health Inc Sees a -4.37% Portfolio Impact (GuruFocus.com)
Feb-15-26 11:40PM	1 Safe-and-Steady Stock with Competitive Advantages and 2 We Brush Off (StockStory)
Feb-11-26 11:02PM	2 Reasons to Like ELV (and 1 Not So Much) (StockStory)
09:47AM	Humana Earnings Reveal Narrower-Than-Expected Loss. Why the Stock Is Falling. (Barrons.com)
07:04AM	Humana Loss Was Narrower Than Expected. Why the Stock Is Falling. (Barrons.com)
Feb-10-26 05:15PM	Humana Earnings Will Shed More Light on Medicare Prospects (Barrons.com)
12:31PM	Quest Diagnostics Incorporated Q4 2025 Earnings Call Summary (Moby)
08:00AM	Is Elevance Health (ELV) Trading at an Attractive Valuation? (Insider Monkey)
Feb-09-26 02:08PM	Encompass Health Q4 Earnings Beat but Discharges Lag (Zacks)
Feb-06-26 01:32PM	Will Declining Medical Membership Affect Humana's Q4 Earnings? (Zacks)
01:23PM	Centene Incurs Q4 Loss, Revenues Up YoY due to PDP Business Strength (Zacks)
11:31AM	Ensign Group Q4 Earnings Beat Estimates on Growing Occupancy (Zacks)
10:41AM	S&P 500 Health Insurer Dives As ACA Enrollment Implodes (Investor's Business Daily)
09:50AM	Molina Healthcare Incurs a Loss in Q4 as Medical Costs Surge (Zacks)
Feb-04-26 06:46AM	UnitedHealth, CVS, Humana Face Double Trouble As Trump's Medicare Cuts Are Just The StartPBM 'Spread Pricing' Comes Under Fire (Benzinga)
12:38AM	5 Revealing Analyst Questions From Elevance Health's Q4 Earnings Call (StockStory)
Feb-03-26 12:36PM	Can Centene's Q4 Earnings Escape Membership & Cost Headwinds? (Zacks)
09:34AM	Adobe downgraded, Palantir upgraded: Wall Street's top analyst calls (The Fly)
03:08AM	UnitedHealth, CVS, Humana Face Double Trouble As Trump's Medicare Cuts Are Just The Start-PBM 'Spread Pricing' Comes Under Fire (Benzinga)
Feb-02-26 11:18AM	Is the Options Market Predicting a Spike in Elevance Health Stock? (Zacks)
10:47AM	Will Rising Costs Hit Molina's Q4 Earnings? Key Insights Here (Zacks)
Jan-31-26 07:48AM	Barclays Adjusts Elevance Health (ELV) PT to $393 While Maintaining Overweight Rating (Insider Monkey)
Jan-29-26 02:44PM	Health Insurance Stock Could Rebound Off Historically Bullish Signal (Schaeffer's Research)
09:13AM	Healthcare ETFs in Focus as UnitedHealth Rises 4% Post Mixed Q4 Results (Zacks)
02:19AM	Trump's Flat Rate Medicare Advantage Proposal Is 'Shock To The System,' Risking 20% Earnings Hit, Delaying Healthcare Turnaround (Benzinga)
12:37AM	ELV Q4 Deep Dive: Margin Pressures and Membership Shifts Shape 2026 Outlook (StockStory)
Jan-28-26 04:32PM	Stocks Finish Mixed as Fed Keeps Interest Rates Steady (Barchart) +5.86%
04:02PM	Elevance Health Inc (ELV) Q4 2025 Earnings Call Highlights: Strong Financial Performance Amid ... (GuruFocus.com)
01:35PM	Analyst Report: Elevance Health, Inc. (Morningstar Research)
01:01PM	Gold Rallies To $5,300, Memory Stocks Go Wild: What's Moving Markets Wednesday? (Benzinga)
12:35PM	Elevance Health Earnings Add to Medicare Pain. Why The Stock Is Rising Anyway. (Barrons.com)
12:21PM	Elevance Health Q4 Earnings Beat Estimates on Increasing Premiums (Zacks)
11:15AM	Stocks Mixed After the Fed Pauses Rate Cuts (Barchart)
10:20AM	Elevance forecasts 2026 profit below estimates, flags revenue decline (Reuters)
10:09AM	Elevance Health Q4 Earnings Call Highlights (MarketBeat)
10:06AM	US Health Insurer Elevance Health Issues Soft Outlook, Lower Premium Forecast For 2026 (Benzinga)
09:30AM	Elevance Health (ELV) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
07:42AM	Elevance Health Stock Dives Again. Why Earnings Are Adding to Medicare Pain. (Barrons.com)
07:10AM	Elevance Health (ELV) Beats Q4 Earnings Estimates (Zacks)

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.

PresidentMs. Gail Koziara Boudreaux

Executive VP & CFOMr. Mark Bradley Kaye

Special AdvisorMr. Peter David Haytaian Esq.

EVP and President of Commercial & Specialty Health BenefitsMr. Charles Morgan Kendrick Jr.

Executive VP & Chief Health Benefits OfficerMs. Felicia Farr Norwood

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Penczek Ronald W	CAO & Controller	Jun 12 '26	Sale	403.16	369	148,766	3,740	Jun 15 04:10 PM
RONALD WILLIAM PENCZEK	Officer	Jun 12 '26	Proposed Sale	403.16	369	148,767		Jun 12 05:27 PM
Dixon Robert L JR	Director	Jun 11 '26	Sale	401.77	151	60,667	10,734	Jun 12 04:12 PM
Dixon Robert L JR	Director	Jun 11 '26	Proposed Sale	401.76	151	60,666		Jun 11 05:10 PM
Penczek Ronald W	CAO & Controller	May 19 '26	Option Exercise	294.30	1,531	450,579	5,640	May 20 04:11 PM
Penczek Ronald W	CAO & Controller	May 19 '26	Sale	403.13	1,531	617,192	4,109	May 20 04:11 PM
RONALD WILLIAM PENCZEK	Officer	May 19 '26	Proposed Sale	403.13	1,531	617,192		May 19 04:25 PM
SCHULMAN AMY W	Director	Mar 12 '26	Sale	287.50	26	7,475	218	Mar 23 04:10 PM
Kendrick Charles Morgan JR	EVP & President, Commercial	Mar 06 '26	Sale	284.92	3,196	910,604	11,791	Mar 09 04:45 PM
CHARLES MORGAN KENDRICK	Officer	Mar 06 '26	Proposed Sale	284.92	3,196	910,593		Mar 06 04:17 PM
COLLIS STEVEN H	Director	Mar 05 '26	Buy	289.84	3,000	869,520	3,639	Mar 06 08:03 AM
DeVore Susan D.	Director	Aug 19 '25	Buy	312.15	1,200	374,580	3,502	Aug 21 04:20 PM
BOUDREAUX GAIL	President and CEO	Jul 18 '25	Buy	286.94	8,500	2,438,951	151,020	Jul 18 01:42 PM

Open in Screener

GUTS

Fractyl Health Inc

0.7430

Jun 26 • 04:00PM ET -0.0559 (-7.00%)

Healthcare Biotechnology USA Micro NASD

GUTS Fractyl Health Inc daily Stock Chart

Peers: AARD AGEN CNTB GALT IMUX KZIA NTHI SPRO TTRX VRCA

| Held by: VTI VXF IWC

Index	-	P/E	-	EPS (ttm)	-1.50	Insider Own	18.24%	Shs Outstand	158.65M	Perf Week	-13.43%
Market Cap	117.88M	Forward P/E	-	EPS next Y	-0.53	Insider Trans	0.60%	Shs Float	129.71M	Perf Month	-13.52%
Enterprise Value	115.53M	PEG	-	EPS next Q	-0.14	Inst Own	35.58%	Short Float	1.79%	Perf Quarter	57.02%
Income	-108.00M	P/S	-	EPS this Y	80.00%	Inst Trans	-20.17%	Short Ratio	1.20	Perf Half Y	-67.12%
Sales	0.00M	P/B	5.51	EPS next Y	-43.80%	ROA	-118.41%	Short Interest	2.32M	Perf YTD	-66.23%
Book/sh	0.13	P/C	1.87	EPS next 5Y	43.25%	ROE	-778.33%	52W High	2.44 -69.61%	Perf Year	-57.30%
Cash/sh	0.40	P/FCF	-	EPS past 3/5Y	-11.63% -16.69%	ROIC	-140.16%	52W Low	0.38 96.98%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.21% 9.47%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	18.45%	Oper. Margin	-	ATR (14)	0.07	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.28	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	45.98	Recom	1.40
Dividend Gr. 3/5Y	- -	Current Ratio	4.28	EPS Q/Q	111.98%	SMA20	-4.88%	Beta	2.28	Target Price	5.24
Payout	-	Debt/Eq	2.84	Sales Q/Q	-	SMA50	-1.75%	Rel Volume	0.78	Prev Close	0.80
Employees	100	LT Debt/Eq	2.60	Earnings	May 12 AMC	SMA200	-31.90%	Avg Volume	1.94M	Price	0.74
IPO	Feb 02, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	137.50% -	Trades		Volume	1,523,402	Change	-7.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-30-26	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$2
Sep-15-25	Initiated	H.C. Wainwright	Buy	$9
Aug-28-25	Initiated	Ladenburg Thalmann	Buy	$3.60
Feb-28-24	Initiated	Evercore ISI	Outperform
Feb-27-24	Initiated	Morgan Stanley	Overweight	$18
Feb-27-24	Initiated	BofA Securities	Buy	$26

Jun-04-26 07:00AM	Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita Procedure (GlobeNewswire)
Jun-01-26 07:00AM	Fractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategy (GlobeNewswire) +7.57%
May-13-26 01:02AM	Fractyl Health Inc (GUTS) Q1 2026 Earnings Call Highlights: Pivotal Trial Progress and ... (GuruFocus.com) +29.20%
May-12-26 04:05PM	Fractyl Health Reports First Quarter 2026 Financial Results and Business Updates (GlobeNewswire)
May-11-26 07:00AM	Fractyl Health Authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes (GlobeNewswire)
06:00AM	Loading…
06:00AM	Inhibrx delivers differentiated cancer drug data; Fractyl starts diabetes gene therapy trial (BioPharma Dive)
May-05-26 07:00AM	Fractyl Health to Report First Quarter 2026 Financial Results and Provide Business Updates on May 12, 2026, and Will Participate in an Upcoming Investor Conference (GlobeNewswire)
Mar-27-26 09:15AM	Scalable Biotech Manufacturing Unlocks a $14B Market (PR Newswire) -5.20%
Mar-25-26 08:30AM	Fractyl Health, Inc. Common Stock Q4 2025 Earnings Call Summary (Moby) +16.17%
Mar-24-26 11:01PM	Fractyl Health Inc (GUTS) Q4 2025 Earnings Call Highlights: Navigating Financial Challenges ... (GuruFocus.com)
04:01PM	Fractyl Health Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates (GlobeNewswire)
Mar-17-26 07:00AM	Fractyl Health to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Updates on March 24, 2026 (GlobeNewswire)
Feb-26-26 07:00AM	Fractyl Health Completes Randomization in REMAIN-1 Pivotal Cohort of Revita for Post-GLP-1 Weight Maintenance (GlobeNewswire) -6.19%
Feb-23-26 09:35AM	Fractyl Health, Inc. (GUTS) Loses 77.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Jan-29-26 01:48PM	Fractyl Health Shares Drop, Eyes New FDA Route For Its Lead Product (Benzinga) -68.04%
12:12PM	Loading…
12:12PM	Fractyl Health Showcases 6-Month REMAIN-1 Data as Revita Curbs Post-GLP-1 Weight Regain (MarketBeat)
07:00AM	Fractyl Health Announces Compelling 6-Month Randomized REMAIN-1 Midpoint Data Showing Durable Weight Maintenance with Revita After GLP-1 Discontinuation (GlobeNewswire)
Jan-06-26 07:00AM	Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness (GlobeNewswire)
Jan-05-26 07:00AM	Fractyl Health Enters a Catalyst-Rich 2026 Positioned to Define the Post-GLP-1 Weight Maintenance Therapeutic Category (GlobeNewswire) -8.44%
Jan-03-26 06:19AM	Analysts Keep Buy Ratings on Fractyl Health (GUTS) (Insider Monkey)
Dec-31-25 11:12AM	Fractyl Health's REVEAL-1 Study Shows Positive Six-Month Results for Revita in Maintaining Weight and Glycemic Control Post-GLP-1 Use (Insider Monkey)
Dec-15-25 05:45PM	Fractyl Health Announces Call of Tranche A Warrants Tied to August 2025 Public Offering Following Achievement of Clinical and Trading Milestones (GlobeNewswire)
Dec-02-25 07:00AM	Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita Procedure (GlobeNewswire) +17.95%
Dec-01-25 07:00AM	Fractyl Health to Participate in the 8th Annual Evercore Healthcare Conference (GlobeNewswire)
Nov-13-25 12:01AM	Fractyl Health Inc (GUTS) Q3 2025 Earnings Call Highlights: Pioneering Weight Loss Solutions ... (GuruFocus.com)
Nov-12-25 04:05PM	Fractyl Health Reports Third Quarter 2025 Results; Revita Clinical Momentum Builds Toward 2026 Pivotal Readout and PMA Filing, Cash Runway Extended into Early 2027 (GlobeNewswire)
Nov-05-25 07:00AM	Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025 (GlobeNewswire)
Oct-21-25 09:20AM	Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions (PR Newswire)
Oct-17-25 09:59AM	Fractyl Health Unveils Potent Preclinical Data for Dual GIP/GLP-1 Gene Therapy RJVA-002 for Obesity (Insider Monkey)
Oct-07-25 07:00AM	Fractyl Health Announces Potent Preclinical Results from RJVA-002, a Dual GIP/GLP-1 Gene Therapy Candidate for Obesity (GlobeNewswire) -6.80%
07:05AM	Loading…
Sep-26-25 07:05AM	Fractyl Health Announces Pricing of $60 Million Underwritten Offering of Common Stock (GlobeNewswire) +32.67%
07:00AM	Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita Maintained Weight Loss After GLP-1 Discontinuation (GlobeNewswire)
Sep-03-25 07:00AM	Fractyl Health Expands Board of Directors with Appointments of Industry Leaders to Advance Clinical Execution and Strategic Growth (GlobeNewswire)
Aug-13-25 03:12AM	Fractyl Health Inc (GUTS) Q2 2025 Earnings Call Highlights: Financial Discipline and Promising ... (GuruFocus.com)
Aug-12-25 04:05PM	Fractyl Health Announces Second Quarter 2025 Financial Results and Business Updates (GlobeNewswire)
Aug-07-25 04:05PM	Fractyl Health Announces Closing of $23 Million Underwritten Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares (GlobeNewswire)
Aug-06-25 04:05PM	Fractyl Health to Report Second Quarter 2025 Financial Results and Provide Business Updates on August 12, 2025, and Will Participate in an Upcoming Investor Conference (GlobeNewswire) -45.99%
08:30AM	Fractyl Health Announces Pricing of $20 Million Underwritten Public Offering (GlobeNewswire)
Aug-05-25 04:15PM	Fractyl Health Announces Proposed Public Offering (GlobeNewswire)
04:02PM	Fractyl Health Reports Potent and Durable Two-Year Real-World Outcomes with Revita Showing Sustained Weight Loss and Improved Glucose Control After a Single Procedure (GlobeNewswire)
Jul-29-25 10:23AM	Canaccord Genuity Reiterates Buy Rating on Fractyl Health (GUTS) (Insider Monkey) -7.61%
Jun-23-25 07:40AM	Fractyl Health Reports Positive 3-Month REVEAL-1 Cohort Data Showing Revita Sustained Weight Loss After GLP-1 Discontinuation, Supporting its Potential as a First-in-Class Weight Maintenance Therapy (GlobeNewswire) -24.77%
07:30AM	Fractyl Health Presents New Data at the American Diabetes Association's 85th Scientific Sessions Demonstrating its Rejuva Smart GLP-1 Pancreatic Gene Therapy Platform Prevents Obesity and Type 2 Diabetes in Preclinical Models (GlobeNewswire)
Jun-18-25 07:00AM	Fractyl Health Reinforces Intellectual Property Leadership in Metabolic Disease with Two New U.S. Patents Directed to Duodenal Resurfacing (GlobeNewswire)
Jun-13-25 11:55AM	Biotech Alert: Searches spiking for these stocks today (TipRanks) -5.07%
07:00AM	Fractyl Health to Present New Preclinical Data from its Rejuva Smart GLP-1 Pancreatic Gene Therapy Platform at the American Diabetes Association's 85th Scientific Sessions (GlobeNewswire)
Jun-04-25 07:00AM	Fractyl Health and Bariendo Sign Letter of Intent to Prepare for Potential Offering of Revita Across its Bariatric and Metabolic Endoscopy Centers Nationwide (GlobeNewswire)
May-19-25 07:00AM	Fractyl Health Advances Rejuva Gene Therapy Platform with Submission of First Clinical Trial Application Module in Europe for RJVA-001 in Type 2 Diabetes (GlobeNewswire) +25.44%
May-17-25 07:15AM	Fractyl Health Unveils New Rejuva Smart GLP-1 Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency and Safety with Limited Systemic GLP-1 Exposure at ASGCT 2025 (GlobeNewswire)
May-13-25 04:05PM	Fractyl Health Announces First Quarter 2025 Financial Results and Business Updates (GlobeNewswire) -13.28%
May-06-25 07:00AM	Fractyl Health to Report First Quarter 2025 Financial Results and Provide Business Updates on May 13, 2025, and Will Participate in an Upcoming Investor Conference (GlobeNewswire) -7.98%
Apr-28-25 04:30PM	Fractyl Health to Present Compelling Preclinical Data from its Rejuva Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting (GlobeNewswire)
Apr-02-25 03:34PM	Fractyl Health, Inc. (GUTS): Insider Were Buying In Q1 2025 (Insider Monkey)
Apr-01-25 07:00AM	Fractyl Health Reports Positive Early Data Showing Revita Has Potential to Prevent Weight Regain After GLP-1 Discontinuation (GlobeNewswire) -6.72%
Mar-03-25 04:05PM	Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates (GlobeNewswire)
Feb-24-25 07:00AM	Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025 (GlobeNewswire)
Feb-12-25 09:35AM	After Plunging -19.55% in 4 Weeks, Here's Why the Trend Might Reverse for Fractyl Health, Inc. (GUTS) (Zacks)
Feb-10-25 03:00AM	Beyond GLP-1s? This biotech is exploring longer-term metabolic treatments (Pharma Voice)
Jan-31-25 08:01AM	Fractyl Health Announces Increased Focus on Groundbreaking Revita Weight Maintenance and Rejuva Pancreatic Gene Therapy Programs with Potential to Deliver Key Clinical Milestones Across Multiple Studies in 2025 (GlobeNewswire) -5.15%
Jan-13-25 07:00AM	Fractyl Health Announces Positive Initial Clinical Results Demonstrating Weight Maintenance Following GLP-1 Discontinuation and Revita Procedure in First Patient of the REVEAL-1 Cohort (GlobeNewswire) +5.41%
Jan-06-25 09:10AM	Heres Why Fractyl Health, Inc. (NASDAQ:GUTS) Is Among the Best Diabetes Stocks to Buy Under $10 (Insider Monkey) -6.36%
Dec-12-24 07:00AM	Fractyl Health Unveils Promising Preclinical Data Demonstrating Safety and Feasibility of Local Delivery of RJVA-001 Rejuva Smart GLP-1 Pancreatic Gene Therapy at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC) (GlobeNewswire)
Dec-09-24 07:00AM	Fractyl Health to Present New Preclinical Data from its Rejuva Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the World Congress Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC) (GlobeNewswire)
Nov-26-24 07:00AM	Fractyl Health to Participate in the Upcoming December Conferences (GlobeNewswire)
Nov-12-24 04:05PM	Fractyl Health Reports Third Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Nov-04-24 04:05PM	Fractyl Health to Present New Preclinical Data on Sustained Weight Maintenance and Blood Sugar from its Rejuva RJVA-001 Single-Administration GLP-1 Pancreatic Gene Therapy Candidate at ObesityWeek 2024 (GlobeNewswire) -9.86% -6.25%
07:00AM	Fractyl Health Presented New Analysis from Pooled Data of Revita Clinical Studies Demonstrating Durable Weight Loss Maintenance for One Year at ObesityWeek 2024 (GlobeNewswire)
Oct-29-24 07:00AM	Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024 (GlobeNewswire) +23.19%
Oct-28-24 07:00AM	Fractyl Health to Present Compelling Weight Maintenance Data from both Revita and Rejuva Platforms at ObesityWeek 2024 (GlobeNewswire) +16.46%
Sep-24-24 07:00AM	Fractyl Health to Present at Chardan's 8th Annual Genetic Medicines Conference (GlobeNewswire)
Sep-03-24 07:00AM	Fractyl Health to Participate in Upcoming September Investor Conferences (GlobeNewswire)
Aug-14-24 04:05PM	Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire) +5.38%
Aug-12-24 10:53AM	Rising diabetes rates spur growth in weight management solutions (Medical Device Network) +14.61%
Aug-08-24 12:13PM	Fractyl Health touts positive year-long weight loss results for Revita device (Clinical Trials Arena) -6.19%
08:00AM	Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single Revita Endoscopic Procedure (GlobeNewswire)
Aug-07-24 07:00AM	Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024 (GlobeNewswire) -9.77%
Jul-30-24 07:00AM	Fractyl Health Receives FDA Breakthrough Device Designation for Revita in Weight Maintenance for People with Obesity Who Discontinue GLP-1 Based Drugs (GlobeNewswire)
Jun-25-24 09:02AM	FDA expands Fractyl endoscopy trial to include untreated diabetes patients (Medical Device Network) -9.22%
07:00AM	Fractyl Health to Present at Piper Sandler 2nd Annual Virtual Obesity Day (GlobeNewswire)
Jun-24-24 06:00AM	Fractyl Health Announces Advancement in Weight Maintenance Pipeline and Business Updates (GlobeNewswire) +5.76%
Jun-23-24 01:30PM	Fractyl Health Presents New Preclinical Data on Sustained Weight Maintenance and Improved Body Composition from its Rejuva Single-Administration GLP-1 Pancreatic Gene Therapy in President's Select Oral Presentation at the American Diabetes Association's 84th Scientific Sessions (GlobeNewswire)
May-29-24 07:00AM	Fractyl Health to Present New Preclinical Obesity Data from Rejuva Platform at the American Diabetes Association's 84th Scientific Sessions (GlobeNewswire)
May-20-24 06:00AM	Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva at Digestive Disease Week 2024 (GlobeNewswire)
May-13-24 08:56PM	GUTS Stock Earnings: Fractyl Health Beats EPS for Q1 2024 (InvestorPlace) +8.52%
04:00PM	Fractyl Health Reports First Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
11:41AM	Fractyl Health Says New Revita Data Show Sustained Weight Loss, Glucose Control in Type 2 Diabetes (MT Newswires)
06:00AM	Fractyl Health Presents Clinical Update on Revita German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D) (GlobeNewswire)
May-08-24 06:00AM	Fractyl Health to Present at BofA Securities 2024 Health Care Conference (GlobeNewswire)
May-07-24 06:00AM	Fractyl Health to Report First Quarter 2024 Financial Results and Provide Business Updates on May 13, 2024 (GlobeNewswire)
Apr-30-24 08:38AM	Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting (GlobeNewswire)
Apr-17-24 03:10PM	The 3 Most Volatile Stocks for Short-Term Traders: April 2024 (InvestorPlace)
Apr-02-24 08:00AM	Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to Spearhead Anticipated Launch Preparation as the Company Conducts Two Pivotal Studies for Revita in Obesity and Type 2 Diabetes (GlobeNewswire) -9.53%
Apr-01-24 07:00AM	Fractyl Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
06:00AM	Fractyl Health Receives FDA IDE Approval for the Revita Remain-1 Pivotal Study of Weight Maintenance in Obesity after Discontinuation of GLP-1 Based Drugs (GlobeNewswire)
Mar-12-24 02:06PM	UPDATE -- Fractyl Health Announces New Results From Its Rejuva Platform Demonstrating Potent and Durable Effects of a Single Dose of a Human GLP-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the db/db Mouse Model of Diabetes and Obesity (GlobeNewswire) -10.34%
08:38AM	Fractyl Health Announces New Results From Its Rejuva Platform Demonstrating Potent and Durable Effects of a Single Dose of a Human GLP-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the db/db Mouse Model of Diabetes and Obesity (GlobeNewswire)
Mar-03-24 01:13PM	Analysts Bet Big on These Beaten-Down IPO Stocks (TipRanks)
Feb-20-24 08:38AM	Fractyl Health Appoints Samuel Conaway to Its Board of Directors, Bolstering New Product Commercial Expertise During Revita Pivotal Clinical Trials (GlobeNewswire)
Feb-01-24 08:08PM	Fractyl Health Announces Pricing of Initial Public Offering (GlobeNewswire)

Fractyl Health, Inc. is a metabolic therapeutics company. It develops medical device solutions for the treatment of metabolic diseases, which includes type 2 diabetes and obesity. The company was founded by Harith Rajagopalan and Jay D. Caplan on August 30, 2010 and is headquartered in Burlington, MA.

Ph.D.Dr. Harith Rajagopalan M.D.

MBAMr. Jay D. Caplan BSEE

General Counsel & Corporate SecretaryMs. Sarah S. Toomey Esq.

CFO & TreasurerMs. Lara Smith Weber

Head of Investor Relations & Corporate DevelopmentMr. Brian Luque

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Royan Ajay	Director	Jun 12 '26	Buy	0.85	23,000	19,596	40,901	Jun 15 06:06 PM
BRADLEY WILLIAM	Director	Jun 10 '26	Buy	0.73	68,493	50,329	84,622	Jun 11 05:04 PM
Sheffield Ian	Director	Jun 10 '26	Buy	0.73	35,000	25,529	35,000	Jun 11 05:00 PM
Rajagopalan Harith	Chief Executive Officer	Jun 10 '26	Buy	0.73	25,000	18,252	540,557	Jun 11 04:59 PM
Smith Weber Lara	Chief Financial Officer	Jun 08 '26	Buy	0.69	20,000	13,708	20,000	Jun 09 06:55 PM
Rajagopalan Harith	Chief Executive Officer	Dec 04 '25	Buy	1.92	10,416	19,999	501,745	Dec 08 07:05 AM

$100 Off + One Summer Month Free Get Elite For Just $199.50

ELV

Elevance Health Inc

GUTS

Fractyl Health Inc

Upgrade your Finviz experience